7V91 fundamentals
An in-depth look to VISIOMED GROUP EO 0,01 operating, investing, and financing activities
7V91 free cash flow for H2 23 is 53 k EUR. For 2023, 7V91 free cash flow was -1.5 M EUR and operating cash flow was 1.11 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM